Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General

Quest Diagnostics Adds Diabetic Retinopathy Screening Through Its Patient Service Centers In Collaboration With IRIS

By Bill Haddad
Today, 10:21 PM
New Capability Enables Individuals Identified as High-Risk by Participating Health Plans to Access Screening through a Quest Diagnostics Site Builds on Quest's Extended Care Services to Improve Care Quality and

DGX

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Citigroup Downgrades Quest Diagnostics to Neutral

By Benzinga Newsdesk
Today, 10:21 PM
Citigroup analyst Patrick Donnelly downgrades Quest Diagnostics (NYSE:DGX) from Buy to Neutral.

DGX

Read More
3 minute read
  • Cannabis
  • Markets
  • News

Positive Drug Tests Among US Workers Higher Than In Last 20 Years; Does That Include Cannabis?

By Nina Zdinjak
Today, 10:21 PM
Which of these is correct? The number of cannabis consumers has increased or more people have stopped concealing their consumption as marijuana legalization spreads across the United States? 

AMZN

Read More
1 minute read
  • Contracts
  • General
  • Government
  • Health Care
  • News

Quest Diagnostics Secures CDC Contract To Support COVID-19 Research

By Vandana Singh
Today, 10:21 PM
The Centers for Disease Control and Prevention (CDC) has granted a contract to Quest Diagnostics Inc (NYSE:DGX) to perform testing and provide…

DGX

Read More
2 minute read
  • Markets
  • Movers
  • Trading Ideas

This Foreboding Sign Looms Over Quest Diagnostics’s Chart

By Benzinga Insights
Today, 10:21 PM
If history is any guide, there may be trouble ahead for shares of Quest Diagnostics (NYSE:DGX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

DGX

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

UBS Downgrades Quest Diagnostics to Neutral, Lowers Price Target to $139

By Benzinga Newsdesk
Today, 10:21 PM
UBS analyst Kevin Caliendo downgrades Quest Diagnostics (NYSE:DGX) from Buy to Neutral and lowers the price target from $160 to $139.

DGX

Read More
1 minute read
  • Analyst Ratings

What 8 Analyst Ratings Have To Say About Quest Diagnostics

By Benzinga Insights
Today, 10:21 PM
Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter:

DGX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Wells Fargo Maintains Equal-Weight on Quest Diagnostics, Lowers Price Target to $145

By Benzinga Newsdesk
Today, 10:21 PM
Wells Fargo analyst Dan Leonard maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and lowers the price target from $160 to $145.

DGX

Read More
1 minute read
  • Dividends
  • Earnings
  • General
  • Guidance
  • Health Care
  • News

Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services

By Vandana Singh
Today, 10:21 PM
Quest Diagnostics Incorporated (NYSE: DGX) posted a better-than-expected 

DGX

Read More
11 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook

Earnings Scheduled For February 3, 2022

By Benzinga Insights
Today, 10:21 PM
  Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter.

ABB

Posts navigation

Previous 1 … 4 5 6 … 13 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service